Targeting low dose androgen-mediated activation of mTOR signaling for the treatment of prostate cancer
Fellowship Grant
Administered By
Pharmacology & Cancer Biology
Awarded By
PhRMA Foundation
Start Date
June 1, 2024
End Date
May 31, 2026
Administered By
Pharmacology & Cancer Biology
Awarded By
PhRMA Foundation
Start Date
June 1, 2024
End Date
May 31, 2026